The global pharmaceutical sector is undergoing a profound transformation as chronic disease management becomes a top priority for healthcare systems worldwide. Central to this shift is the Acarbose API market, a specialized segment within the diabetes care vertical that is gaining significant traction. Acarbose, a potent alpha-glucosidase inhibitor, plays a vital role in managing type 2...